… Our phase III clinical trial of pirfenidone for patients with idiopathic pulmonary fibrosis (IPF)
revealed the efficacy in reducing the decline of vital capacity (VC) and increasing the …

… Idiopathic pulmonary fibrosis (IPF), also referred to as cryptogenic fibrosing alveolitis, is a …
Although the pathologic features of inflammation and fibrosis are widely appreciated, other …

… Idiopathic pulmonary fibrosis (IPF) is a generally fatal disorder with a reported median
survival of 3 to 6 yr. This has been based on relatively few studies with diagnoses inconsistently …

… In this study, we investigated the frequency and clinical significance of commonly measured
circulating autoantibodies in a well-characterized cohort of patients with IPF. We sought to …

… We propose the following definition for acute exacerbation of IPF: an acute, clinically
significant deterioration of unidentifiable cause in a patient with underlying IPF. Proposed …

… Idiopathic pulmonary fibrosis, the most common and fatal form of ILD, was initially believed
to be due to an inflammatory response to unknown lung injury, whereas nowadays it is …

… The clinical course of idiopathic pulmonary fibrosis (IPF) is characterized by a gradual
decline in pulmonary function, which eventually results in mortality [1]. Although the prognosis of …

… clinical significance of the serologic domain of IPAF has not yet been established in idiopathic
pulmonary fibrosis … (IPF) is a chronic disease characterized by pulmonary fibrosis and …

Idiopathic pulmonary fibrosis (IPF) is the most common and lethal form of idiopathic interstitial
pneumonia. The disease is thought to arise following an aberrant reparative response to …

… ) and assessed the relationships between serum SP-D levels and clinical symptoms in these
patients. Moreover, we compared the clinical significance of serum SP-D and KL-6 levels. …